“Perspective: An Integrated Vision of the Quality of Life in Breast Cancer Survivorship Trajectory”

2024-10-1

The impact of extensive intraductal component (EIC) on the genomic risk of recurrence in early hormone receptor positive breast cancer

2024-10-1

Efficacy and safety of oncoplastic breast-conserving surgery versus conventional breast-conserving surgery: an updated meta-analysis

2024-10-1

Management and outcomes for older women with early breast cancer treated with primary endocrine therapy (PET)

2024-10-1

Questionnaire survey and analysis of drug clinical research implementation capabilities of breast cancer treatment departments in Chinese hospitals

2024-10-1

Factors influencing 5-year persistence to adjuvant endocrine therapy in young women with breast cancer

2024-10-1

Postoperative complications of hypofractionated and conventional fractionated radiation therapy in patients with implant-based breast reconstruction: A systematic review and meta-analysis

2024-10-1

Psychometric properties of patient-reported outcomes Common Terminology Criteria for adverse events (PRO-CTCAE®) in breast cancer patients: The prospective observational multicenter VIP study

2024-10-1

Non-invasive prediction of axillary lymph node dissection exemption in breast cancer patients post-neoadjuvant therapy: A radiomics and deep learning analysis on longitudinal DCE-MRI data

2024-10-1

Digital breast tomosynthesis for breast cancer diagnosis in women with dense breasts and additional breast cancer risk factors: A systematic review

2024-10-1

Olaparib plus trastuzumab in HER2-positive advanced breast cancer patients with germline BRCA1/2 mutations: the OPHELIA phase 2 study

2024-10-1

Meta-analysis of intraoperative electron radiation therapy for partial breast irradiation in early breast cancer

2024-10-1

Editorial Board

2024-9-10

Can we counterbalance restricted access to innovation through specialized breast cancer care? The REAL-NOTE study

2024-9-2

Atypical ductal or lobular hyperplasia, lobular carcinoma in-situ, flat epithelial atypia, and future risk of developing breast cancer: Systematic review and meta-analysis

2024-9-1

Metronomic chemotherapy using capecitabine and cyclophosphamide in metastatic breast cancer – efficacy, tolerability and quality of life results from the phase II METRO trial

2024-9-1

Diagnostic Efficacy of Multimodal Ultrasound for Mass and Non-Mass Enhancements in Dynamic Contrast-Enhanced MRI of Idiopathic Granulomatous Mastitis and Breast Cancer

2024-9-1

Stereotactic Body Radiotherapy using CyberKnife versus Interstitial Brachytherapy in Accelerated Partial Breast Irradiation on Left-sided Breast: A Comparison of Dosimetric Characteristics and Preliminary Clinical Results

2024-9-1

Role of [18F]FDG PET/CT in patients with no special type breast cancer: Literature review and comparison between guidelines

2024-9-1

Effect of different exercise types on quality of life in patients with breast cancer: A network meta-analysis of randomized controlled trials

2024-9-1

Estimating the risk of major adverse cardiac events following radiotherapy for left breast cancer using a modified generalized Lyman normal-tissue complication probability model

2024-8-12

Women's views on using artificial intelligence in breast cancer screening: A review and qualitative study to guide breast screening services

2024-8-1

Locoregional recurrence in studies of primary systemic therapy in early invasive breast cancer

2024-8-1

Use of Tamoxifene-Controlled Ovarian Hyperstimulation for fertility preservation before breast cancer treatment: a prospective cohort study with a 5-year follow-up

2024-8-1

Body composition in early breast cancer patients treated with adjuvant aromatase inhibitors: does dietary counseling matter?

2024-8-1

Impact of neoadjuvant compared to adjuvant chemotherapy on prognosis in patients with hormone-receptor positive / HER2-negative breast cancer: A propensity score matching population-based study

2024-8-1

Real-world prevalence, treatment and survival of “high risk” early breast cancer, with mandatory testing of gBRCA1/2 mutation according to the OlympiA trial inclusion criteria: Data from a population-based registry

2024-8-1

Neoadjuvant Chemotherapy for Breast Cancer in Italy: A Senonetwork Analysis of 37,215 Patients Treated from 2017 to 2022

2024-8-1

The Features of Male Breast Cancer in China: A Real-world Study

2024-8-1

Clinicopathological characteristics and genomic profiling of pure mucinous breast cancer

2024-8-1

Major pathologic response and long-term clinical benefit in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative breast cancer after neoadjuvant chemotherapy

2024-8-1

The impact of age on physical functioning after treatment for breast cancer, as measured by patient-reported outcome measures: a systematic review.

2024-8-1

Comprehensive Analysis of Stereotactic Radiosurgery Outcomes in Triple-Negative Breast Cancer Patients with Brain Metastases: The Influence of Immunotherapy and Prognostic Factors

2024-8-1

6th and 7th International Consensus Guidelines for the management of advanced breast cancer (ABC Guidelines 6 and 7)

2024-8-1

Managing Sexual Health Challenges in Breast Cancer Survivors: A Comprehensive Review

2024-8-1

“Positioning of Tucatinib in the new clinical scenario of HER2-positive metastatic breast cancer: an Italian and Spanish consensus paper”.

2024-8-1

IMPACT OF THE GENOMIC SIGNATURE OF 70-GENES FOR BREAST CANCER IN THE PUBLIC SYSTEM AND IN SUPPLEMENTARY HEALTH CARE IN A COUNTRY OF MEDIUM SOCIOECONOMIC DEVELOPMENT

2024-8-1

Impact of coadministration of proton-pump inhibitors and palbociclib in hormone receptor-positive/HER2-negative advanced breast cancer

2024-8-1

Capturing Longer Term Surgical Outcome Measures as Part of Routine Care of Breast Cancer Patients

2024-8-1

Screening optimal candidates with operable, early-stage triple-negative breast cancer benefitting from capecitabine maintenance: A post-hoc analysis of the SYSUCC-001 study

2024-8-1

Prediction of response to neoadjuvant chemotherapy by MammaTyper® across breast cancer subtypes: A retrospective cross-sectional study

2024-8-1

Diagnostic Accuracy of Intraoperative Methods for Margin Assessment in Breast Cancer Surgery: A Systematic review & Meta-analysis

2024-8-1

Editorial Board

2024-7-16

Adjuvant endocrine therapy choices in premenopausal patients with hormone receptor-positive early breast cancer: Insights from the prospective GIM23-POSTER study

2024-7-9

DCIS knowledge of women choosing between active surveillance and surgery for low-risk DCIS

2024-7-2

Cropsi study: Efficacy and safety of cryotherapy and cryocompression in the prevention of chemotherapy-induced peripheral neuropathy in patients with breast and gynecological cancer–A prospective, randomized trial

2024-6-26

A systematic review and meta-analysis of intraoperative electron radiation therapy delivered with a dedicated mobile linac for partial breast irradiation in early breast cancer

2024-6-4

Erratum to ‘The benefit of adding polygenic risk scores, lifestyle factors, and breast density to family history and genetic status for breast cancer risk and surveillance classification of unaffected women from germline CHEK2 c.1100delC families’ [The Breast 73 (2024) 103611]

2024-6-1

French college of gynecologists and obstetricians (CNGOF) recommendations for clinical practice: Place of breast self-examination in screening strategies

2024-6-1

Factors influencing the time to diagnosis and treatment of breast cancer among women in low- and middle-income countries: A systematic review

2024-6-1